The anti-hyperglycemic efficacy of a lipid-lowering drug Daming capsule and the underlying signaling mechanisms in a rat model of diabetes mellitus
Zhang Y, Li X, Li J, Zhang Q, Chen X, Liu X, Zhang Y, Zhang H, Yang H, Hu Y, Wu X, Li X, Ju J, Yang B. The anti-hyperglycemic efficacy of a lipid-lowering drug Daming capsule and the underlying signaling mechanisms in a rat model of diabetes mellitus. Scientific Reports 2016, 6: 34284. PMID: 27721485, PMCID: PMC5056381, DOI: 10.1038/srep34284.Peer-Reviewed Original ResearchConceptsDaming capsuleGLP-1Diabetes mellitusRat modelDiabetic ratsRat model of diabetes mellitusModel of diabetes mellitusRegulatory pathwaysClinical treatmentLipid-lowering drugsSecretion of GLP-1Expression of TCF7L2DM ratsClinical treatment of diabetesGIP secretionBlood lipidsTreatment of diabetesAnti-hyperglycemic effectBlood glucose homeostasisMetabolic disordersRatsGlucose levelsTherapeutic drugsSignaling pathwayGlucose homeostasis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply